These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38321412)

  • 1. Correction: PTEN-induced kinase 1 gene single-nucleotide variants as biomarkers in adjuvant chemotherapy for colorectal cancer: a retrospective study.
    Mihara Y; Hirasaki M; Horita Y; Fujino T; Fukushima H; Kamakura Y; Uranishi K; Hirano Y; Ryozawa S; Yasuda M; Makino Y; Shibazaki S; Hamaguchi T
    BMC Gastroenterol; 2024 Feb; 24(1):67. PubMed ID: 38321412
    [No Abstract]   [Full Text] [Related]  

  • 2. PTEN-induced kinase 1 gene single-nucleotide variants as biomarkers in adjuvant chemotherapy for colorectal cancer: a retrospective study.
    Mihara Y; Hirasaki M; Horita Y; Fujino T; Fukushima H; Kamakura Y; Uranishi K; Hirano Y; Ryozawa S; Yasuda M; Makino Y; Shibazaki S; Hamaguchi T
    BMC Gastroenterol; 2023 Oct; 23(1):339. PubMed ID: 37784019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction to: PTEN-induced kinase 1 gene single-nucleotide variants as biomarkers in adjuvant chemotherapy for colorectal cancer: a retrospective study.
    Mihara Y; Hirasaki M; Horita Y; Fujino T; Fukushima H; Kamakura Y; Uranishi K; Hirano Y; Ryozawa S; Yasuda M; Makino Y; Shibazaki S; Hamaguchi T
    BMC Gastroenterol; 2023 Oct; 23(1):373. PubMed ID: 37907839
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative sequence analysis of patient-matched primary colorectal cancer, metastatic, and recurrent metastatic tumors after adjuvant FOLFOX chemotherapy.
    Harada K; Okamoto W; Mimaki S; Kawamoto Y; Bando H; Yamashita R; Yuki S; Yoshino T; Komatsu Y; Ohtsu A; Sakamoto N; Tsuchihara K
    BMC Cancer; 2019 Mar; 19(1):255. PubMed ID: 30898102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteins of the VEGFR and EGFR pathway as predictive markers for adjuvant treatment in patients with stage II/III colorectal cancer: results of the FOGT-4 trial.
    Thomaidis T; Maderer A; Formentini A; Bauer S; Trautmann M; Schwarz M; Neumann W; Kittner JM; Schad A; Link KH; Rey JW; Weinmann A; Hoffman A; Galle PR; Kornmann M; Moehler M
    J Exp Clin Cancer Res; 2014 Oct; 33(1):83. PubMed ID: 25272957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression of PTEN and phosphorylated Akt are not correlated with clinical outcome in breast cancer patients treated with trastuzumab-containing neo-adjuvant chemotherapy.
    Yonemori K; Tsuta K; Shimizu C; Hatanaka Y; Hashizume K; Ono M; Kouno T; Ando M; Tamura K; Katsumata N; Hasegawa T; Kinoshita T; Fujiwara Y
    Med Oncol; 2009; 26(3):344-9. PubMed ID: 19016009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations between microsatellite instability, ERCC1/XRCC1 polymorphism and clinical characteristics, and FOLFOX adjuvant chemotherapy effect of colorectal cancer patients.
    Zhang L; Zhao J; Yu B; Song X; Sun G; Han L; Wang L; Dong S
    Cancer Genet; 2017 Dec; 218-219():51-57. PubMed ID: 29153096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A network-based predictive gene-expression signature for adjuvant chemotherapy benefit in stage II colorectal cancer.
    Cao B; Luo L; Feng L; Ma S; Chen T; Ren Y; Zha X; Cheng S; Zhang K; Chen C
    BMC Cancer; 2017 Dec; 17(1):844. PubMed ID: 29237416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of genetic variations in the PI3K/PTEN/AKT/mTOR pathway in Korean patients with colorectal cancer.
    Kim JG; Chae YS; Sohn SK; Kang BW; Moon JH; Lee SJ; Jeon SW; Park JS; Park JY; Choi GS
    Oncology; 2010; 79(3-4):278-82. PubMed ID: 21412012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-mediated transfer of the PTEN gene inhibits human colorectal cancer growth in vitro and in vivo.
    Saito Y; Swanson X; Mhashilkar AM; Oida Y; Schrock R; Branch CD; Chada S; Zumstein L; Ramesh R
    Gene Ther; 2003 Nov; 10(23):1961-9. PubMed ID: 14528320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemistry-Based Consensus Molecular Subtypes as a Prognostic and Predictive Biomarker for Adjuvant Chemotherapy in Patients with Stage II Colorectal Cancer.
    Li Y; Yao Q; Zhang L; Mo S; Cai S; Huang D; Peng J
    Oncologist; 2020 Dec; 25(12):e1968-e1979. PubMed ID: 32926498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of an Enhanced Recovery Protocol Is Associated With On-Time Initiation of Adjuvant Chemotherapy in Colorectal Cancer.
    Hassinger TE; Mehaffey JH; Martin AN; Bauer-Nilsen K; Turrentine FE; Thiele RH; Sarosiek BM; Reilley MJ; Hoang SC; Friel CM; Hedrick TL
    Dis Colon Rectum; 2019 Nov; 62(11):1305-1315. PubMed ID: 31567924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative C-reactive protein/albumin ratio is a biomarker of risk of recurrence and need for adjuvant chemotherapy for stage III colorectal cancer.
    Matsuoka H; Ando K; Hu Q; Zaitsu Y; Tsuda Y; Hisamatsu Y; Nakashima Y; Kimura Y; Oki E; Mori M
    Int J Clin Oncol; 2020 Jul; 25(7):1318-1326. PubMed ID: 32279124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of PD-L1 genetic variation on the prognosis of R0 resection colorectal cancer patients received capecitabine-based adjuvant chemotherapy: a long-term follow-up, real-world retrospective study.
    Su J; Dai B; Yuan W; Wang G; Zhang Z; Li Z; Liu J; Song J
    Cancer Chemother Pharmacol; 2020 May; 85(5):969-978. PubMed ID: 32314029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression.
    Fang L; Li H; Wang L; Hu J; Jin T; Wang J; Yang BB
    Oncotarget; 2014 May; 5(10):2974-87. PubMed ID: 24912422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Adjuvant Chemotherapy on Stoma-Related Complications After Surgery for Colorectal Cancer: A Retrospective Analysis.
    Oliphant R; Czerniewski A; Robertson I; McNulty C; Waterston A; Macdonald A
    J Wound Ostomy Continence Nurs; 2015; 42(5):494-8. PubMed ID: 26336047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using oral tegafur/uracil (UFT) plus leucovorin as adjuvant chemotherapy in stage II colorectal cancer: a propensity score matching study from Taiwan.
    Yu YL; Tseng WK; Liao CK; Yeh CY; Chen HH; Liu YH; Liaw YW; Fan CW
    BMC Cancer; 2023 Sep; 23(1):900. PubMed ID: 37749535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High level of unmet needs and anxiety are associated with delayed initiation of adjuvant chemotherapy for colorectal cancer patients.
    Zhu L; Tong YX; Xu XS; Xiao AT; Zhang YJ; Zhang S
    Support Care Cancer; 2020 Nov; 28(11):5299-5306. PubMed ID: 32112352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of interhospital variation in adjuvant chemotherapy for patients with Stage II/III colorectal cancer: a nationwide study.
    Arakawa K; Kawai K; Tanaka T; Hata K; Sugihara K; Nozawa H
    Colorectal Dis; 2018 Jul; 20(7):O162-O172. PubMed ID: 29752849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Survival Benefits of 5-Fluorouracil-Based Adjuvant Chemotherapy for Patients With Microsatellite-Stable Stage III Colorectal Cancer According to the Tumor Budding Status: A Retrospective Analysis.
    Yamadera M; Shinto E; Kajiwara Y; Mochizuki S; Okamoto K; Hase K; Yamamoto J; Ueno H
    Dis Colon Rectum; 2019 Nov; 62(11):1316-1325. PubMed ID: 31567925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.